Health Alert: CMS Issues Guidance on Controlling Fraud, Waste, and Abuse for Medicare Part D Sponsors
2/14/2006
On February 8, 2006, the Centers for Medicare and Medicaid Services (CMS) updated its guidance for Sponsors of Medicare Part D prescription drug plans on detecting, correcting, and preventing fraud, waste, and abuse (FWA). The guidance, which was 63 pages long, is an update to Chapter 9 of the Prescription Drug Benefit Manual, and it expands on an eight-page summary document issued last June. CMS will accept comments on the draft guidance until March 1, 2006.
This publication provides you with a list of the FWA compliance program basics, information on self-reporting and potential fraud schemes/risk areas.
